BIO-TECHNE Corp Quarterly Nonoperating Income (Expense) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BIO-TECHNE Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2010 to Q3 2024.
  • BIO-TECHNE Corp Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $184K.
  • BIO-TECHNE Corp Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$14.5M, a 3.73% decline year-over-year.
  • BIO-TECHNE Corp annual Nonoperating Income (Expense) for 2024 was -$21M, a 153% decline from 2023.
  • BIO-TECHNE Corp annual Nonoperating Income (Expense) for 2023 was $39.7M, a 728% increase from 2022.
  • BIO-TECHNE Corp annual Nonoperating Income (Expense) for 2022 was $4.8M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.5M $184K +$6.49M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 -$21M -$4.16M +$2.05M +32.9% Apr 1, 2024 Jun 30, 2024 10-K 2024-08-22
Q1 2024 -$23M -$5.91M -$5.9M -39327% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$17.1M -$4.62M -$3.16M -216% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 -$14M -$6.3M -$53.7M -113% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $39.7M -$6.21M -$4.69M -308% Apr 1, 2023 Jun 30, 2023 10-K 2024-08-22
Q1 2023 $44.4M -$15K +$21.7M +99.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $22.7M -$1.46M -$25.3M -106% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $48M $47.4M +$43.2M +1039% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $4.8M -$1.52M +$59.9M +97.5% Apr 1, 2022 Jun 30, 2022 10-K 2024-08-22
Q1 2022 -$55.2M -$21.7M +$1.6M +6.86% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$56.7M $23.8M +$18.5M +344% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 -$75.2M $4.16M +$13.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$89.1M -$61.5M -$83.7M -377% Apr 1, 2021 Jun 30, 2021 10-K 2023-08-23
Q1 2021 -$5.44M -$23.3M -$22.3M -2299% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $16.9M $5.37M -$108M -95.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-07
Q3 2020 $125M -$9.75M +$5.77M +37.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $119M $22.2M +$42.7M Apr 1, 2020 Jun 30, 2020 10-K 2022-08-24
Q1 2020 $76.4M -$970K -$6.76M -117% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $83.1M $113M +$125M Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-08
Q3 2019 -$42M -$15.5M -$7.34M -89.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$34.7M -$20.5M -$33.8M -253% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-25
Q1 2019 -$869K $5.79M +$23.9M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$24.8M -$11.8M -$9.42M -390% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 -$15.3M -$8.18M -$5.11M -167% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$10.2M $13.4M +$15.6M Apr 1, 2018 Jun 30, 2018 10-K 2020-08-26
Q1 2018 -$25.8M -$18.1M -$15.7M -667% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$10M -$2.42M +$276K +10.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 -$10.3M -$3.06M -$1.69M -123% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$8.62M -$2.2M +$44K +1.96% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-11-06
Q1 2017 -$8.67M -$2.36M -$1.32M -128% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$7.34M -$2.69M -$2.04M -314% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 -$5.3M -$1.37M -$2.19M -268% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$3.11M -$2.24M -$2.68M -608% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-27
Q1 2016 -$429K -$1.04M -$370K -55.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$59K -$651K -$8.63M -108% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $8.58M $818K +$1.44M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $7.14M $441K -$164K -27.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-07
Q1 2015 $7.3M -$667K -$967K -322% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $8.27M $7.98M +$7.51M +1584% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $761K -$618K -$881K -335% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.64M $605K -$343K -36.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-29
Q1 2014 $1.99M $300K -$220K -42.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $2.21M $474K -$68K -12.5% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $2.27M $263K +$80K +43.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $2.19M $948K +$1.55M Apr 1, 2013 Jun 30, 2013 10-K 2015-08-31
Q1 2013 $644K $520K +$3.68M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$3.03M $542K +$351K +184% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-04
Q3 2012 -$3.38M $183K +$630K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$4.01M -$601K -$969K -263% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-29
Q1 2012 -$3.05M -$3.16M -$3.8M -589% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $758K $191K -$131K -40.7% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-11
Q3 2011 $889K -$447K -$1.04M -176% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $1.93M $368K Apr 1, 2011 Jun 30, 2011 10-K 2013-08-29
Q1 2011 $646K +$855K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $322K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-07
Q3 2010 $590K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q1 2010 -$209K Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.